An Open Label, Single-Dose Study of 14C-NW-3509 in Healthy Male Subjects

NCT03446274 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Evenamide

Sponsor

Newron Pharmaceuticals SPA